RU2003115986A - METHOD FOR TREATING SENSON-NEURAL Hearing Aid - Google Patents

METHOD FOR TREATING SENSON-NEURAL Hearing Aid

Info

Publication number
RU2003115986A
RU2003115986A RU2003115986/14A RU2003115986A RU2003115986A RU 2003115986 A RU2003115986 A RU 2003115986A RU 2003115986/14 A RU2003115986/14 A RU 2003115986/14A RU 2003115986 A RU2003115986 A RU 2003115986A RU 2003115986 A RU2003115986 A RU 2003115986A
Authority
RU
Russia
Prior art keywords
senson
treating
hearing aid
neural hearing
neural
Prior art date
Application number
RU2003115986/14A
Other languages
Russian (ru)
Other versions
RU2232014C1 (en
Inventor
Татьяна Викторовна Золотова
Александр Григорьевич Волков
Елена Анатольевна Костенко
Original Assignee
Татьяна Викторовна Золотова
Александр Григорьевич Волков
Елена Анатольевна Костенко
Filing date
Publication date
Application filed by Татьяна Викторовна Золотова, Александр Григорьевич Волков, Елена Анатольевна Костенко filed Critical Татьяна Викторовна Золотова
Priority to RU2003115986/14A priority Critical patent/RU2232014C1/en
Priority claimed from RU2003115986/14A external-priority patent/RU2232014C1/en
Application granted granted Critical
Publication of RU2232014C1 publication Critical patent/RU2232014C1/en
Publication of RU2003115986A publication Critical patent/RU2003115986A/en

Links

Claims (1)

Способ лечения сенсоневральной тугоухости путем внутривенного ведения активного вещества, отличающийся тем, что осуществляют введение перфторана, в количестве 2,5-3,0 мл/кг веса больного в сочетании с ингаляцией 40-45%-ной воздушно-кислородной смеси, подаваемой в течение 10 мин до введения перфторана и повторно в течение 10 мин после него.A method for the treatment of sensorineural hearing loss by intravenous administration of the active substance, characterized in that the administration of perfluorane is carried out in an amount of 2.5-3.0 ml / kg of the patient’s weight in combination with inhalation of a 40-45% air-oxygen mixture supplied during 10 min before the introduction of perftoran and again within 10 min after it.
RU2003115986/14A 2003-05-28 2003-05-28 Method for treating sensoneural impaired hearing RU2232014C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003115986/14A RU2232014C1 (en) 2003-05-28 2003-05-28 Method for treating sensoneural impaired hearing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003115986/14A RU2232014C1 (en) 2003-05-28 2003-05-28 Method for treating sensoneural impaired hearing

Publications (2)

Publication Number Publication Date
RU2232014C1 RU2232014C1 (en) 2004-07-10
RU2003115986A true RU2003115986A (en) 2004-11-27

Family

ID=33414515

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003115986/14A RU2232014C1 (en) 2003-05-28 2003-05-28 Method for treating sensoneural impaired hearing

Country Status (1)

Country Link
RU (1) RU2232014C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2524303C1 (en) * 2013-01-09 2014-07-27 Региональный некоммерческий фонд поддержки и развития петербургской науки, культуры и спорта Method of treating perceptive hearing loss

Similar Documents

Publication Publication Date Title
CY1125544T1 (en) 1,2,4-OXADIAZOLOBENZOIC ACID COMPOUNDS AND THEIR USE FOR NON-SENSITIVE SEDATION AND IN THE THERAPEUTIC TREATMENT OF DISEASE
EP1713453A4 (en) Implantable drug delivery device including wire filaments
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
SK12792001A3 (en) Pharmaceutical composition for treating neurointoxications, preparation containing xenon or xenon gas mixture and method for producing an inhalation agent
RU2002127804A (en) MEDICINAL SYSTEM FOR TREATMENT OF COMPLICATIONS CONNECTED WITH DIABETES AND NEUROPATHY, AND THEIR APPLICATION
EA200101206A1 (en) APPLICATION OF BIORABLABLE MICROSPHERES, RELAXING ANTI-SCIENT AGENT, FOR TREATMENT OF GLYOBLASTOMA
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
MX2022008342A (en) Methods of treating conditions related to the s1p1 receptor.
DE602005025347D1 (en) OLIGORIBONUCLEOTIDES AND METHODS FOR THEIR USE IN THE TREATMENT OF FIBROTIC SUDDEN AND OTHER DISEASES
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
WO2005004854A3 (en) Use of betaine for treating arteritis
RU2003115986A (en) METHOD FOR TREATING SENSON-NEURAL Hearing Aid
SE0102887D0 (en) New formulation
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
WO2006016351A3 (en) Drug delivery in the coronary sinus
SE9800905D0 (en) New therapy in glomerulonephritis
PT1572686E (en) Anthranilic acid amide derivatives and their pharmaceutical use
DE60235965D1 (en) COMBINATION OF LEVOSIMENDAN AND A CALCIUM SOURCE FOR THE TREATMENT OF HEART FAILURE
RU2524303C1 (en) Method of treating perceptive hearing loss
RU2001132588A (en) New Use of Substances for PMS
RU2000108520A (en) METHOD FOR RESTORING TREATMENT OF OSTEOARTHROSIS PATIENTS
EP1752147A4 (en) Drug for prevention or treatment of diabetes
RU2001120483A (en) A method for the treatment of patients with sensorineural hearing loss in the acute period
DE502004007021D1 (en) Use of phenazone for the treatment of migraine